Brief: Innocan Pharma Corp Now Sees U.S IPO Of 1.1 Million Units - SEC Filing
30/09/2025 22:33
Sept 30 (Reuters) - Innocan Pharma Corp IP40.F: INNOCAN PHARMA CORP: NOW SEES IPO OF 1.1 MILLION UNITS - SEC FILING INNOCAN PHARMA CORP - ESTIMATED IPO PRICE SET AT $13.962 PER UNIT - SEC FILING Source text: [ID:n0001493152-25-016393] Further company coverage: IP40.F (((( Reuters.Briefs@thomsonreuters.com ;));))
Recent news on Innocan Pharma
See all newsBrief: Innocan Pharma Corp To Offer Up To 3.75 Million Units In IPO - SEC Filing
Brief: Innocan Pharma Announces Promising Results Of LPT-CBD Administered To Gottingen Minipigs
Brief: Innocan Pharma Corp - Liposomal Cbd Injection Technology Patent Allowed In Japan
Brief: Innocan Pharma Corp Now Sees U.S IPO Of 1.1 Million Units - SEC Filing
Brief: Innocan Pharma Announces Details Of Proposed Share Consolidation